Antiviral activity of cidofovir and ribavirin against the new human adenovirus subtype 14a that is associated with severe pneumonia.
Darr
Sebastian
S
Madisch
Ijad
I
Heim
Albert
A
D000257:Adenoviridae Infections / Q000453:epidemiology / Q000821:virology*; D000260:Adenoviruses, Human / Q000187:drug effects*; D000998:Antiviral Agents / Q000494:pharmacology*; D000077404:Cidofovir; D003596:Cytosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D020128:Inhibitory Concentration 50; D063065:Organophosphonates / Q000494:pharmacology*; D011024:Pneumonia, Viral / Q000453:epidemiology / Q000821:virology*; D012254:Ribavirin / Q000494:pharmacology*; D014481:United States / Q000453:epidemiology
D000998:Antiviral Agents; D063065:Organophosphonates; D012254:Ribavirin; D003596:Cytosine; D000077404:Cidofovir